Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells

Toshiyuki Nanbu(Meikai University), Jun Shimada(Meikai University)
Oncology Reports
November 21, 2017
Cited by 7


Related Papers